HSR Waiting Period Expires for TruBridge Acquisition by IKS Health
TBRG sits 88% above its 52-week low of $13.88.
Summary
TruBridge announced that the HSR antitrust waiting period for its acquisition by IKS Health has expired, moving the all-cash deal closer to completion.
Key Events · M&A and Partnerships · TBRG
-
HSR Waiting Period Expiration
The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) expired on June 22, 2026, removing a significant regulatory condition for the merger.
-
Acquisition Progress
This development moves TruBridge closer to completing its all-cash acquisition by IKS Health for $26.25 per share, initially announced on April 23, 2026.
-
Remaining Conditions
The merger remains subject to other customary closing conditions, including approval by TruBridge shareholders.
Analysis · TBRG · Technology
The expiration of the Hart-Scott-Rodino (HSR) Act waiting period removes a key regulatory hurdle for TruBridge's acquisition by IKS Health. This is a significant step towards closing the all-cash deal, which is priced at $26.25 per share. The remaining major condition is shareholder approval, for which a definitive proxy statement was filed on June 4, 2026.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 36.9% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TBRG was trading at $26.11 on NASDAQ in the Technology sector, with a market capitalization of approximately $391.6M. The 52-week trading range was $13.88 to $26.51. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.